A seven long-noncoding RNA signature predicts prognosis of lung squamous cell carcinoma

This study profiled differentially expressed long noncoding RNAs (lncRNAs) in lung squamous cell carcinoma (LSCC) to predict LSCC overall survival (OS) using The Cancer Genome Atlas data. The RNA-seq and clinical dataset of 475 LSCC patients was retrieved from The Cancer Genome Atlas database and st...

Full description

Saved in:
Bibliographic Details
Published inBiomarkers in medicine Vol. 14; no. 1; pp. 53 - 63
Main Authors Li, Shuai, Teng, Yue, Yuan, Min-Jie, Ma, Ting-Ting, Ma, Jian, Gao, Xu-Jie
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.01.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This study profiled differentially expressed long noncoding RNAs (lncRNAs) in lung squamous cell carcinoma (LSCC) to predict LSCC overall survival (OS) using The Cancer Genome Atlas data. The RNA-seq and clinical dataset of 475 LSCC patients was retrieved from The Cancer Genome Atlas database and statistically analyzed. There were 67 upregulated and 32 downregulated lncRNAs in LSCCs and 12 lncRNAs associated with OS. The seven-lncRNA signature was associated with poor OS and RP11-150O12.6 and CTA-384D8.35 were associated with better OS (p < 0.001). The seven lncRNAs-mRNA interaction network analysis showed their association with 187 protein-coding genes for cancer development, cell migration, adhesion, proliferation, apoptosis, angiogenesis and the MAPK signaling pathways. This seven-lncRNA signature is useful to predict LSCC OS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1752-0363
1752-0371
DOI:10.2217/bmm-2019-0282